Overview and Scope

• Overview and Scope

Market Engineering Analysis of the Japanese Hyperlipidemia Market (1996-2006)

• Market Definitions
• Market Engineering Research Measurement System
• Challenges Facing the Antihyperlipidemic Market in Japan
• Market Engineering Valuation and Revenue Forecasts (1996-2006)
• Market Engineering Research Analysis of Hyperlipidemia
• Competitive Structure
• Products in the Pipeline

Market Engineering Strategic Recommendations

• Market Engineering Strategic Recommendations
• Add Value to Products by Preventing New Risk Factors for Arterioscelerosis
• Develop Combination Drug Therapy forHyperlipidemia; Hypertension and Diabetes
• Focus on Superiority of New HMG-CoA Reductase Inhibitors in Terms of Its Reduced Side Effects
• Explore Other Markets Where Efficacy Is the Primary Criterion for Antihyperlipidemia Product Selection
• Strengthen Rapport with Doctors by Providing Value Added Information
• Develop Complementary Antihyperlipidemics for HMG-CoA Reductase Inhibitors